Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology

CGON

    • Home
    • CGON
cg-oncology-rises-after-expediting-a-late-stage-trial-readout-for-lead-asset
Biotechnology CGON Uncategorized

CG Oncology rises after expediting a late-stage trial readout for lead asset

Jan 9, 2026

On the Move Comments spawns CG Oncology (CGON) shares climbed ~31% on Friday after the...

ABVX Biotechnology CGON CNTA JANX LLY MDGL RCUS RVMD SLDB Uncategorized

Here are the most and least likely M&A targets in biotech, according to Truist

Dec 23, 2025
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.